Ad
related to: kinase
Search results
Conference MDAngle: ASCO 2024 Chronic Myeloid Leukemia
Medscape· 7 days agoDr Jorge Cortes previews compelling studies at ASCO 2024 in CML, including updates on OPTIC's 4-year...
ASCO 2024 | Ascentage Pharma Releases Latest Results from Multiple Clinical Studies of Its Lead Drug...
FOX21 Colorado Springs· 6 days agoAscentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that its ...
New Type of Reversible Male Contraception Proves a Success in Mouse Study
ScienceAlert via Yahoo News· 2 days agoResearchers discovered the sperm-slowing activity of CDD-2807 in a bank of possible drugs. It stood out because of its ability to inhibit a protein called serine/threonine kinase< ...
PARP inhibition leads to synthetic lethality with key splicing-factor mutations in myelodysplastic...
Nature· 2 days agoSplicing factors are frequently mutated in patients with myelodysplastic syndromes and acute myeloid leukaemia. Recent studies have revealed convergent molecular defects caused by splicing factor ...
In vitro generation of genetic diversity for directed evolution by error-prone artificial DNA...
Nature· 6 days agoError-prone artificial DNA synthesis (epADS) is presented as an effective method for in vitro generation of genetic diversity for directed evolution of various types of genetic parts, synthetic gene circuits and even microbes.
Roche's (RHHBY) Inavolisib NDA Gets FDA Priority Review Tag
Zacks· 21 hours agoThe FDA grants priority review to Roche's (RHHBY) NDA for the inavolisib combination regimen for advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation.
Update on the STING signaling pathway in developing nonalcoholic fatty liver disease
Medical Xpress· 5 days agoNonalcoholic fatty liver disease (NAFLD) has become the most prevalent chronic liver condition worldwide, affecting about 25% of the global population due to the increasing rates of obesity ...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 14 hours agoImmunocore converts Phase 2/3 TEBE-AM clinical trial into registrational Phase 3 trial evaluating KIMMTRAK for previously treated advanced cutaneous melanoma Following recent consultation with FDA, all patients randomized from start of TEBE-AM
MD Anderson Research Highlights: ASCO 2024 Special | Newswise
Newswise· 7 days agoThe University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These
Exploring the pathways of drug repurposing and Panax ginseng treatment mechanisms in chronic heart...
Nature· 3 days agoChronic Heart Failure (CHF) is a significant global public health issue, with high mortality and morbidity rates and associated costs. Disease modules, which are collections of disease-related ...